Form D — Ansa Biotechnologies, Inc.
0001231919-25-000275 · filed 2025-10-02
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $55,477,037
- Total sold
- $45,199,665
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Ansa Biotechnologies, Inc.
- CIK
- 1816722
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 1198 65TH STREET #250
EMERYVILLE, CA 94608 - Phone
- 9256908100
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Jason T. Gammack · Executive OfficerEmeryville, CA Find on LinkedIn ↗
-
Daniel Lin-Arlow · Executive OfficerEmeryville, CA Find on LinkedIn ↗
-
Yanniv Dorone · DirectorEmeryville, CA Find on LinkedIn ↗
-
Matthew McManus · DirectorEmeryville, CA Find on LinkedIn ↗
-
Chenny Zhang · DirectorEmeryville, CA Find on LinkedIn ↗
-
Sebastian Palluk · Executive OfficerEmeryville, CA Find on LinkedIn ↗
View original on SEC EDGAR.